Clinical Trials · NCT03101930
Cardiovascular Effects of GLP-1 Receptor Activation
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Vanderbilt University Medical Center
- Enrollment
- 329
- Start date
- May 2017
- Locations
- 1 site, United States
- Primary endpoint
- Change in Flow-mediated Dilation